Jinu Abraham

This study develops a novel transmembrane STING agonist and validates its efficacy in genetically humanized mice, showing enhanced immune and antitumor responses.

This study compares molecular and immune responses to diverse STING agonists to identify differences in potency and immune outcomes.

This paper develops a probabilistic model integrating sequencing and functional assay data to predict personalized drug combinations for sarcoma patients with exhausted treatment options.